• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Coronavirus disease 2019 vaccine hypersensitivity evaluated with vaccine and excipient allergy skin testing.通过疫苗和辅料过敏皮肤试验评估2019冠状病毒病疫苗超敏反应
Ann Allergy Asthma Immunol. 2022 Jan;128(1):97-98. doi: 10.1016/j.anai.2021.08.417. Epub 2021 Sep 3.
2
Non-immunoglobulin E-mediated allergy associated with Pfizer-BioNTech coronavirus disease 2019 vaccine excipient polyethylene glycol.与辉瑞-生物科技公司2019冠状病毒病疫苗辅料聚乙二醇相关的非免疫球蛋白E介导的过敏反应
Ann Allergy Asthma Immunol. 2021 Dec;127(6):694-696. doi: 10.1016/j.anai.2021.09.012. Epub 2021 Sep 20.
3
Utility and futility of skin testing to address concerns surrounding messenger RNA coronavirus disease 2019 vaccine reactions.评估信使 RNA 新冠病毒疫苗反应相关问题时，皮肤试验的效用和无效性。
Ann Allergy Asthma Immunol. 2022 Feb;128(2):153-160. doi: 10.1016/j.anai.2021.11.006. Epub 2021 Nov 16.
4
Excipients as Potential Agents of Anaphylaxis in Vaccines: Analyzing the Formulations of Currently Authorized COVID-19 Vaccines.疫苗中作为潜在过敏反应介质的辅料：分析当前获批的新冠疫苗配方
J Investig Allergol Clin Immunol. 2021 Feb 17;31(1):92-93. doi: 10.18176/jiaci.0667. Epub 2020 Jan 12.
5
The Century of mRNA Vaccines: COVID-19 Vaccines and Allergy.mRNA疫苗的世纪：新冠疫苗与过敏
J Investig Allergol Clin Immunol. 2021 Feb 17;31(1):89-91. doi: 10.18176/jiaci.0665. Epub 2020 Jan 4.
6
Skin atrophy after skin tests with corticosteroids for the diagnosis of SARS-CoV-2 vaccine excipients hypersensitivity.使用皮质类固醇进行皮肤试验以诊断SARS-CoV-2疫苗辅料超敏反应后的皮肤萎缩。
Eur Ann Allergy Clin Immunol. 2023 Nov;55(6):319-322. doi: 10.23822/EurAnnACI.1764-1489.282. Epub 2023 Jan 13.
7
Diagnostic accuracy of vaccine and vaccine excipient testing in the setting of allergic reactions to COVID-19 vaccines: A systematic review and meta-analysis.COVID-19 疫苗过敏反应疫苗和疫苗赋形剂检测的诊断准确性：系统评价和荟萃分析。
Allergy. 2023 Jan;78(1):71-83. doi: 10.1111/all.15571. Epub 2022 Nov 23.
8
Safety of New mRNA Vaccines Against COVID-19 in Severely Allergic Patients.新型mRNA新冠疫苗在重度过敏患者中的安全性
J Investig Allergol Clin Immunol. 2021 Apr 20;31(2):180-181. doi: 10.18176/jiaci.0683. Epub 2021 Mar 2.
9
Delayed systemic urticarial reactions following mRNA COVID-19 vaccination.mRNA COVID-19 疫苗接种后迟发性全身性荨麻疹反应。
Allergy Asthma Proc. 2022 Jan 1;43(1):40-43. doi: 10.2500/aap.2022.43.210101.
10
National assessment strategy for adults and children with a history of vaccine allergy shows low utility of COVID-19 vaccine skin testing.针对有疫苗过敏史的成人和儿童的国家评估策略显示，新冠疫苗皮肤测试的效用较低。
Pediatr Allergy Immunol. 2023 Feb;34(2):e13923. doi: 10.1111/pai.13923.

引用本文的文献

1
The conundrum of COVID-19 mRNA vaccine-induced anaphylaxis.新型冠状病毒肺炎信使核糖核酸疫苗诱导的过敏反应难题。
J Allergy Clin Immunol Glob. 2023 Feb;2(1):1-13. doi: 10.1016/j.jacig.2022.10.003. Epub 2022 Dec 13.
2
Diagnostic accuracy of vaccine and vaccine excipient testing in the setting of allergic reactions to COVID-19 vaccines: A systematic review and meta-analysis.COVID-19 疫苗过敏反应疫苗和疫苗赋形剂检测的诊断准确性：系统评价和荟萃分析。
Allergy. 2023 Jan;78(1):71-83. doi: 10.1111/all.15571. Epub 2022 Nov 23.
3
Coronavirus disease 2019 vaccine administration in patients with reported reactions to polyethylene glycol- and polysorbate-containing therapeutics.2019 年冠状病毒病疫苗在有报告称对含聚乙二醇和聚山梨酯的治疗药物有反应的患者中的给药。
Ann Allergy Asthma Immunol. 2022 Jul;129(1):88-94.e1. doi: 10.1016/j.anai.2022.03.006. Epub 2022 Mar 12.
4
Coronavirus disease 2019 messenger RNA vaccine skin tests and serum histamine levels in allergic reactions.2019冠状病毒病信使核糖核酸疫苗皮肤试验及过敏反应中的血清组胺水平
Ann Allergy Asthma Immunol. 2022 Mar;128(3):339. doi: 10.1016/j.anai.2021.12.014.
5
Immune parameters during anaphylaxis to messenger RNA coronavirus disease 2019 vaccines: Not the usual suspects?2019年冠状病毒病信使核糖核酸疫苗过敏反应期间的免疫参数：并非常见因素？
Ann Allergy Asthma Immunol. 2022 Mar;128(3):338-339. doi: 10.1016/j.anai.2021.11.012.
6
Risk of Second Allergic Reaction to SARS-CoV-2 Vaccines: A Systematic Review and Meta-analysis.新型冠状病毒疫苗二次过敏反应风险：系统评价和荟萃分析。
JAMA Intern Med. 2022 Apr 1;182(4):376-385. doi: 10.1001/jamainternmed.2021.8515.
7
Utility of skin testing in assessment of post-AZD1222 vaccine (AstraZeneca) allergic reactions: case series in Vietnam.皮肤试验在评估AZD1222疫苗（阿斯利康）过敏反应中的效用：越南的病例系列研究
Asia Pac Allergy. 2021 Oct 22;11(4):e40. doi: 10.5415/apallergy.2021.11.e40. eCollection 2021 Oct.

本文引用的文献

1
The Risk of Allergic Reaction to SARS-CoV-2 Vaccines and Recommended Evaluation and Management: A Systematic Review, Meta-Analysis, GRADE Assessment, and International Consensus Approach.新型冠状病毒疫苗过敏反应风险及推荐评估和管理：系统评价、荟萃分析、GRADE 评估和国际共识方法。
J Allergy Clin Immunol Pract. 2021 Oct;9(10):3546-3567. doi: 10.1016/j.jaip.2021.06.006. Epub 2021 Jun 18.
2
Allergic symptoms after mRNA COVID-19 vaccination and risk of incomplete vaccination.新型冠状病毒 mRNA 疫苗接种后的过敏症状及未完成全程接种的风险
J Allergy Clin Immunol Pract. 2021 Aug;9(8):3200-3202.e1. doi: 10.1016/j.jaip.2021.05.031. Epub 2021 Jun 11.
3
Anaphylaxis to the first dose of mRNA SARS-CoV-2 vaccines: Don't give up on the second dose!对第一剂新型冠状病毒mRNA疫苗的过敏反应：不要放弃接种第二剂！
Allergy. 2021 Sep;76(9):2916-2920. doi: 10.1111/all.14958. Epub 2021 Jun 9.
4
COVID-19 Vaccination in Patients with Reported Allergic Reactions: Updated Evidence and Suggested Approach.有过敏反应报告的患者的COVID-19疫苗接种：最新证据与建议方法
J Allergy Clin Immunol Pract. 2021 Jun;9(6):2135-2138. doi: 10.1016/j.jaip.2021.03.053. Epub 2021 Apr 15.
5
Administration of a Second Dose of the Moderna COVID-19 Vaccine After an Immediate Hypersensitivity Reaction With the First Dose: Two Case Reports.首剂 Moderna COVID-19 疫苗立即发生超敏反应后接种第二剂：两例病例报告
Ann Intern Med. 2021 Aug;174(8):1177-1178. doi: 10.7326/L21-0104. Epub 2021 Apr 6.
6
Misdiagnosis of systemic allergic reactions to mRNA COVID-19 vaccines.新冠mRNA疫苗全身性过敏反应的误诊
Ann Allergy Asthma Immunol. 2021 Jul;127(1):133-134. doi: 10.1016/j.anai.2021.03.024. Epub 2021 Mar 27.
7
Polyethylene glycol and polysorbate skin testing in the evaluation of coronavirus disease 2019 vaccine reactions: Early report.聚乙二醇和聚山梨酯皮肤试验在评估2019冠状病毒病疫苗反应中的应用：早期报告
Ann Allergy Asthma Immunol. 2021 Jun;126(6):735-738. doi: 10.1016/j.anai.2021.03.012. Epub 2021 Mar 26.
8
Safety of New mRNA Vaccines Against COVID-19 in Severely Allergic Patients.新型mRNA新冠疫苗在重度过敏患者中的安全性
J Investig Allergol Clin Immunol. 2021 Apr 20;31(2):180-181. doi: 10.18176/jiaci.0683. Epub 2021 Mar 2.
9
Reports of Anaphylaxis After Receipt of mRNA COVID-19 Vaccines in the US-December 14, 2020-January 18, 2021.2020年12月14日至2021年1月18日美国接种mRNA新冠疫苗后发生过敏反应的报告
JAMA. 2021 Mar 16;325(11):1101-1102. doi: 10.1001/jama.2021.1967.
10
mRNA Vaccines to Prevent COVID-19 Disease and Reported Allergic Reactions: Current Evidence and Suggested Approach.mRNA 疫苗预防 COVID-19 疾病和报告的过敏反应：当前证据和建议方法。
J Allergy Clin Immunol Pract. 2021 Apr;9(4):1423-1437. doi: 10.1016/j.jaip.2020.12.047. Epub 2020 Dec 31.

Coronavirus disease 2019 vaccine hypersensitivity evaluated with vaccine and excipient allergy skin testing.

作者信息

Kohli-Pamnani Anita, Zapata Kristen, Gibson Tiffany, Kwittken Pamela L

机构信息

Allergy, Asthma & Immunology Center, LLC, 40 Commerce Park, Milford, CT 06460.

Allergy, Asthma & Immunology Center, LLC, 40 Commerce Park, Milford, CT 06460.

出版信息

Ann Allergy Asthma Immunol. 2022 Jan;128(1):97-98. doi: 10.1016/j.anai.2021.08.417. Epub 2021 Sep 3.

DOI:10.1016/j.anai.2021.08.417
PMID:34487840
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8413483/
Abstract
摘要